跳至主要内容
临床试验/CTIS2023-509003-32-00
CTIS2023-509003-32-00招募中1 期

Vancomycin treatment in critically ill adults using model-informed precision dosing tool – prospective low-intervention clinical trial. (ProVanc) - PROVANC1.0

Tartu University Hospital0 个研究点目标入组 56 人开始时间: 2023年10月27日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
入组人数
56

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • Age =18 years, Admitted to the tertiary intensive care unit in Tartu University Hospital, Patient has indication (assessed by treating doctor) to start intravenous vancomycin treatment

排除标准

  • Patient has been previously enrolled into this study during ongoing hospital record, Patient has previously received vancomycin within last 7 days, Intravenous treatment with vancomycin has begun more than 24h before enrolment to study, The treating physician considers the patient not suitable for the study, There is no intention for vancomycin therapeutic drug monitoring, Continues intravenous vancomycin administration is used

研究者

相似试验